Collective X Health Secures $3.2 Million Funding to Revolutionize Women's Health Research and Data Access

Collective X Health Unveils $3.2 Million Pre-Seed Funding Round

In an exciting development for women's health, Collective X Health (CX) has officially launched, backed by an impressive pre-seed funding of $3.2 million. This funding round, which was oversubscribed, was co-led by Council Capital and Anthemis Female Innovators Lab Fund, complemented by investments from notable entities like SoGal Ventures, Emerson Collective, Muse Capital, and Segal Ventures.

Addressing the Gender Data Gap

The co-founder and Chief Research Officer, Dr. Stacy Sims, emphasized the urgent need for solutions in women's health. The historical exclusion of women from clinical trials, particularly in NIH-funded research, has led to a substantial gap in understanding female physiology. AI models trained predominantly on male data often yield ineffective care and misdiagnosis for women—a serious issue CX aims to tackle.

"Women have been systematically excluded from health research, with generational consequences," Dr. Sims stated. Collective X Health intends to bridge this gap by combining vetted academic research with commercial scalability. The platform serves as a comprehensive repository of data tailored specifically for women's health, enabling companies and healthcare providers to develop products and services that truly meet the needs of half the population.

Transforming Research into Actionable Insights

Central to CX’s strategy is the transformation of peer-reviewed research and gender-specific data into a structured, auditable intelligence layer that can be effectively licensed through an API. Unlike mainstream AI solutions that often lack specificity, Collective X holds itself accountable by consistently citing its sources, thereby ensuring every insight is substantiated by rigorous research.

Lindsey Abramo, CX’s Co-Founder and CEO, highlighted the critical nature of this endeavor: "Every company claiming to serve women should be able to show the research behind that claim." This reflects CX's commitment to fostering transparency in the women's health sector.

A Scientific Backbone

a
The backbone of CX is the Research Lead Collective, a panel of more than 20 esteemed MDs and PhDs, spearheaded by Dr. Sims. This dedicated team meticulously reviews and validates the research underpinning CX’s offerings. To further enhance research efforts, CX has instituted a grants program, initially seeded with $200,000 from human performance firm Momentous to stimulate gender data gap research in sports science.

Entering strategic partnerships with acknowledged academic journals and organizations like the Open Medicine Foundation and WildAI, Collective X has set sights on expanding its reach through a growing list of prospective collaborations.

Expanding Insights and Shaping the Future

Current funding will be directed toward scaling research depth across various life stages and health conditions, enhancing its data intelligence, and responding to burgeoning enterprise demand. The leadership team comprises seasoned professionals including Dr. Stacy Sims, Lindsey Abramo, and Angelica Marden, all committed to advancing women's health knowledge with a firm grasp of the market's needs.

Rachel Tsui, Partner at Council Capital, expressed confidence in CX's potential to become a cornerstone resource for women’s health insights, praising the team's blend of scientific acumen and media expertise.

About Collective X Health

Collective X Health aspires to be the leading B2B platform providing wearables, digital health platforms, sports teams, and performance brands with insightful, research-backed intelligence rooted in female physiology. By prioritizing women's health, CX not only aims to improve health outcomes but also paves the way for transformative research in this crucial field.

To learn more about how Collective X Health is reshaping the landscape of women's health research, visit their website at collectivex.health.